news
03-18-2022, 10:35 PM
Cramer's lightning round: Hims & Hers Health is not a buy (https://news.google.com/__i/rss/rd/articles/CBMiWmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjIvMDMvMTgvY3 JhbWVycy1saWdodG5pbmctcm91bmQtaGltcy1oZXJzLWhlYWx0 aC1pcy1ub3QtYS1idXkuaHRtbNIBXmh0dHBzOi8vd3d3LmNuYm MuY29tL2FtcC8yMDIyLzAzLzE4L2NyYW1lcnMtbGlnaHRuaW5n LXJvdW5kLWhpbXMtaGVycy1oZWFsdGgtaXMtbm90LWEtYnV5Lm h0bWw?oc=5) CNBC
Pharma will move higher, but Oppenheimer's Holz is hesitant on valuations (https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3LnlvdXR1YmUuY29tL3dhdGNoP3Y9Qk 1fMEdZdUpOUjTSAQA?oc=5) CNBC Television
More... (https://news.google.com/__i/rss/rd/articles/CBMiWmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjIvMDMvMTgvY3 JhbWVycy1saWdodG5pbmctcm91bmQtaGltcy1oZXJzLWhlYWx0 aC1pcy1ub3QtYS1idXkuaHRtbNIBXmh0dHBzOi8vd3d3LmNuYm MuY29tL2FtcC8yMDIyLzAzLzE4L2NyYW1lcnMtbGlnaHRuaW5n LXJvdW5kLWhpbXMtaGVycy1oZWFsdGgtaXMtbm90LWEtYnV5Lm h0bWw?oc=5)
Pharma will move higher, but Oppenheimer's Holz is hesitant on valuations (https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3LnlvdXR1YmUuY29tL3dhdGNoP3Y9Qk 1fMEdZdUpOUjTSAQA?oc=5) CNBC Television
More... (https://news.google.com/__i/rss/rd/articles/CBMiWmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjIvMDMvMTgvY3 JhbWVycy1saWdodG5pbmctcm91bmQtaGltcy1oZXJzLWhlYWx0 aC1pcy1ub3QtYS1idXkuaHRtbNIBXmh0dHBzOi8vd3d3LmNuYm MuY29tL2FtcC8yMDIyLzAzLzE4L2NyYW1lcnMtbGlnaHRuaW5n LXJvdW5kLWhpbXMtaGVycy1oZWFsdGgtaXMtbm90LWEtYnV5Lm h0bWw?oc=5)